|
Market Closed -
NYSE
21:03:19 15/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 102.03 USD | -1.03% |
|
-3.31% | -18.56% |
| 09-15 | Abbott Announces First Canadian Use of Volt Pulsed Field Ablation System to Treat Atrial Fibrillation | CI |
| 09-14 | Abbott Laboratories to Pay $385 Million to Settle Infant Formula Allegations | MT |
| Market Cap | 177B 153B 145B 131B 246B 16,936B 248B 1,726B 664B 8,587B 663B 648B 27,386B | P/E 2026 * |
28.9x | P/E 2027 * | 22.4x |
|---|---|---|---|---|---|
| Enterprise Value | 200B 174B 164B 149B 279B 19,232B 281B 1,960B 754B 9,752B 753B 736B 31,100B | EV / Sales 2026 * |
3.99x | EV / Sales 2027 * | 3.62x |
| Free-Float |
86.16% | Yield 2026 * |
2.52% | Yield 2027 * | 2.69% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ABT | Delayed | |
CBOE
| ABT | Real-time | |
London S.E.
| ABT | Delayed | |
Xetra
| ABL | Delayed | |
Tradegate
| ABL | Real-time | |
Boerse Muenchen
| ABL | Real-time | |
Deutsche Boerse AG
| ABL | Delayed | |
Mexican S.E.
| ABT * | End-of-day quote | |
Kazakhstan S.E.
| ABT_KZ | End-of-day quote | |
Swiss Exchange
| ABT | Delayed | |
CBOE
| Real-time | ||
Lima
| ABTUS | End-of-day quote | |
Wiener Boerse
| ABT | End-of-day quote | |
Santiago S.E.
| ABT | End-of-day quote | |
CBOE
| ABT | Real-time | |
Santiago S.E.
| ABTCL | End-of-day quote | |
Börse Stuttgart
| ABL | Delayed | |
Borsa Italiana
| 1ABT | End-of-day quote |
Last Transcript: Abbott Laboratories
| 1 day | +0.25% | ||
| 1 week | -3.31% | ||
| Current month | -7.55% | ||
| 1 month | -8.29% | ||
| 3 months | +15.07% | ||
| 6 months | -5.55% | ||
| Current year | -18.56% |
| 1 week | 101.47 | 105.19 | |
| 1 month | 101.47 | 117.34 | |
| Current year | 81.97 | 129.46 | |
| 1 year | 81.97 | 137.49 | |
| 3 years | 81.97 | 141.23 | |
| 5 years | 81.97 | 142.6 | |
| 10 years | 37.38 | 142.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 30/03/2020 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 31/08/2023 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 08/12/2011 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 08/12/2011 |
Daniel Starks
BRD | Director/Board Member | 71 | 15/02/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 02/09/26 | Sell | Controller/Auditor | -27 | 0.0000% | ||
| 01/09/26 | Tax | Chief Financial Officer | -388 | 0.0000% | ||
| 25/08/26 | Exercice | Chief Executive Officer | 1,196,496 | 0.0691% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.03% | -3.31% | -22.31% | +0.29% | 177B | ||
| -0.05% | +1.47% | +0.34% | +14.65% | 120B | ||
| -0.90% | -0.43% | +10.94% | +81.33% | 61.69B | ||
| +1.65% | +3.81% | +0.10% | -29.51% | 50.64B | ||
| +0.27% | -3.53% | +3.35% | +39.11% | 48.16B | ||
| +2.09% | +2.27% | +14.38% | -10.28% | 32.62B | ||
| -1.47% | -7.44% | - | - | 28.17B | ||
| +2.76% | +8.07% | +41.73% | -7.40% | 25.69B | ||
| +0.07% | -1.06% | -10.97% | +3.77% | 21.33B | ||
| -1.58% | -3.74% | -15.14% | -8.37% | 20.5B | ||
| Average | +0.70% | -1.47% | +2.49% | +9.29% | 58.53B | |
| Weighted average by Cap. | +0.39% | -1.33% | -3.70% | +11.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.2B 43.49B 41.12B 37.23B 69.87B 4,816B 70.4B 491B 189B 2,442B 189B 184B 7,788B | 54.53B 47.23B 44.66B 40.43B 75.89B 5,231B 76.46B 533B 205B 2,652B 205B 200B 8,458B |
| Net income | 6.3B 5.46B 5.16B 4.67B 8.77B 605B 8.84B 61.61B 23.7B 307B 23.68B 23.15B 978B | 7.98B 6.91B 6.53B 5.92B 11.1B 765B 11.19B 77.98B 30B 388B 29.97B 29.3B 1,237B |
| Net Debt | 23.94B 20.74B 19.61B 17.75B 33.32B 2,296B 33.57B 234B 90.02B 1,164B 89.92B 87.93B 3,713B | 20.96B 18.15B 17.17B 15.54B 29.17B 2,010B 29.39B 205B 78.81B 1,019B 78.72B 76.98B 3,251B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/09/26 | US$102.03 | -1.03% | 7,419,476 |
| 14/09/26 | US$103.09 | +1.12% | 7,792,131 |
| 11/09/26 | US$101.95 | -1.36% | 8,398,311 |
| 10/09/26 | US$103.36 | -1.78% | 7,845,268 |
| 09/09/26 | US$105.23 | -0.27% | 6,470,872 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
Select your edition
All financial news and data tailored to specific country editions


















